Toolkit for Optimal Recovery after Orthopedic Injury for Orthopedic Injury
Study Summary
This trial is testing a mind-body program to prevent persistent pain and disability in at-risk patients with an acute orthopedic injury, compared to usual care. The trial is testing the feasibility of the program delivery and assessment methods, to see if they meet the benchmarks necessary for the success of the subsequent efficacy trial.
- Acute Orthopedic Injury
Treatment Effectiveness
Effectiveness Progress
Study Objectives
5 Primary · 27 Secondary · Reporting Duration: throughout the study completion, on average of 3 years
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Minimally Enhanced Usual Care (MEUC) - Control
1 of 2
Toolkit for Optimal Recovery after Orthopedic Injury - Active
1 of 2
Active Control
Experimental Treatment
180 Total Participants · 2 Treatment Groups
Primary Treatment: Toolkit for Optimal Recovery after Orthopedic Injury · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 8 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Who else is applying?
What state do they live in?
Massachusetts | 100.0% |
What portion of applicants met pre-screening criteria?
Met criteria | 100.0% |
Frequently Asked Questions
Are there any opportunities to be involved in this experiment currently available?
"According to the clinicaltrials.gov information, this experiment is presently in need of volunteers. Initially posted on September 15th 2021, it was most recently updated on March 23rd 2022." - Anonymous Online Contributor
What is the principal aim of this medical experiment?
"This trial strives to determine the acceptability of TOR for patients in a three-year timeframe. Secondary objectives include gauging randomization and adherence, assessing appropriateness as perceived by research staff, and measuring pain levels with the Numerical Rating Scale (NRS)." - Anonymous Online Contributor
What is the aggregate amount of participants enrolled in this trial?
"Indeed, according to clinicaltrials.gov the study published on September 15th 2021 is actively recruiting for 180 patients at a single site. The trial was last updated on March 23rd 2022." - Anonymous Online Contributor